‘NHS workforce plan will take years, indeed decades to come to fruition’


Share post:

The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.

Welcoming its publication Alison Jones, PDA Director of Policy said: “It gives greater clarity around the future direction and strategy for professional development, training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development of the clinical role of pharmacists to support better patient care.

“However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire life course.

Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are regularly highlighted through activities, such as the safer pharmacies survey.

“The details of this plan, and how soon the goals can be achieved will be of great importance to pharmacists working at the frontline of NHS care.

The practical delivery of the plan goes well beyond the NHS itself, with universities and employers among those who will need to also contribute. The PDA wants to engage with all stakeholders to ensure the interests of individuals are adequately represented throughout the period covered by the plan.”

Of interest to PDA members will be NHS England’s aims around – Increasing the number of training places for pharmacists each year, including the consideration of pharmacy degree apprenticeships; Expanding the pharmacy technician role to support skill-mix; The continuation of the Additional Roles Reimbursement Scheme (ARRS); The role of technology, for example, hub and spoke models; and The requirement to increase the number of Designated Prescribing Practitioners (DPPs) to support the independent prescribing agenda.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...